# Axillary Reverse Mapping (ARM) Technique

> **NCT03109522** · NA · UNKNOWN · sponsor: **McMaster University** · enrollment: 130 (estimated)

## Conditions studied

- Invasive Breast Cancer
- Ductal Carcinoma in Situ of the Breast

## Interventions

- **PROCEDURE:** axillary reverse mapping (ARM)
- **PROCEDURE:** Standard axillary surgery (SLNB or ALND)

## Key facts

- **NCT ID:** NCT03109522
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2020-02-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03109522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03109522, "Axillary Reverse Mapping (ARM) Technique". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03109522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*